Akkadeas Pharma
http://www.akkadeaspharma.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Akkadeas Pharma
Biopharma Quarterly Deal-Making Statistics, Q1 2017
Biopharma financing decreased by 29% in the first quarter of 2017; conversely, M&As set a record, reaching $61.9 billion. The largest alliance of the quarter involved the microbiome.
Ipsen's Latest Consumer Health Play: Growth Or Attracting Suitors?
Less than a month after investing in Italian nutritional supplement maker Akkadeas Pharma, Ipsen acquires five Sanofi OTC drug brands marketed in Europe, including Prontalgine analgesics available in France.
Ipsen's Latest Consumer Health Play: Growth Or Attracting Suitors?
Less than a month after investing in Italian nutritional supplement maker Akkadeas Pharma, Ipsen acquires five Sanofi OTC drug brands marketed in Europe, including Prontalgine analgesics available in France.
Company Information
- Industry
- Medical Devices
-
Pharmaceuticals
- Nutraceuticals
- OTC, Consumer
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice